Related Experiment Video
Updated: Sep 17, 2025
09:28
Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
Published on: May 18, 2020
8.6K
One Decade In and Counting: How 503B Outsourcing Facilities Are Finding Their Place in the Industry.
Michael R Alexander1, Blinn E Combs1, Brad Howard2
1Brown & Fortunato, P.C., Amarillo and Dallas, Texas.
International Journal of Pharmaceutical Compounding
|June 29, 2025
Summary
The Drug Quality and Security Act of 2013 established outsourcing facilities. This summary reviews their current role and future prospects in the healthcare market.
Area of Science:
- Pharmaceutical Sciences
- Health Policy and Law
Background:
- The Drug Quality and Security Act of 2013 introduced Section 503B, establishing outsourcing facilities.
- Approximately 90 outsourcing facilities have registered with the U.S. Food and Drug Administration (FDA) since the act's passage.
- Industry participants are integrating outsourcing facility services into their practices.
Purpose of the Study:
- To assess the current landscape and future trajectory of outsourcing facilities.
- To understand the evolving role of outsourcing facilities within the healthcare market.
Main Methods:
- Review of legislative impact and market integration.
- Analysis of industry adoption and operational roles.
Main Results:
- Outsourcing facilities have become an integrated part of the pharmaceutical supply chain.
- The market is actively defining the specific functions and value of these facilities.
Conclusions:
- Outsourcing facilities play a significant and growing role in the pharmaceutical sector.
- Further evolution is expected as the healthcare market continues to adapt to their services.
More Related Videos
07:48A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
22.4K
06:24Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
10.2K
Related Concept Videos
01:03Drug Control Governance: Regulatory Bodies and Their Impact
257
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
257
01:25Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
01:26Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
182
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
182
01:28Biopharmaceutics and Pharmacokinetics: Overview
2.6K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.6K
01:28Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K